In the present study, we analysed the expression of MCT1, MCT2, MCT4, CD147 and gp70, in prostate cancer, corresponding adjacent non-neoplastic tissue, normal tissue and PIN lesions, and sought for associations with the clinico-pathological data of the patients. Here, SLC16A1 is linked to prostate intraepithelial neoplasia.